Despite Endo International plc – Ordinary Shares (NASDAQ:ENDP) delivering a second-quarter earnings beat on Tuesday, with the management team forced to pull back …
William Blair analyst Tim Lugo reiterates a Market Perform rating on shares of Endo International plc (NASDAQ:ENDP), following the news that the FDA has requested the …
Endo International plc (NASDAQ:ENDP) is on investors’ radars after the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug …
William Blair analyst Tim Lugo is quite apprehensive on Endo International plc – Ordinary Shares (NASDAQ:ENDP) on the heels of yesterday morning’s review materials …
On Wednesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) announced that it has dosed the first patient in the Phase III ESEENCE trial for patients with …
Sarepta Therapeutics Inc (NASDAQ:SRPT) announced yesterday that the Patent Trial and Appeal Board issued two favorable decisions for Sarepta over an intellectual property and …
On Monday, September 19th, the FDA granted accelerated approval to Sarepta Therapeutics Inc (NASDAQ:SRPT) pipeline drug eteplirsen (Exondys 51), designed to treat exon …
In a research report issued Friday, William Blair analyst Tim Lugo reiterated a Market Perform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), after …
In a research report released today, William Blair analyst Tim Lugo reiterated a Market Perform rating on shares of Zogenix, Inc. (NASDAQ:ZGNX), after the company reported …
In a research report released Tuesday, William Blair analyst Tim Lugo reiterated an Outperform rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with a …
